MyVisionTest News Archive

Displaying news items tagged with wet AMD (More tags »)
SELECT PAGE
First <<  1 2 3 4 5 6 7 8 9 10   >> Last

Lucentis
Mar 28, 2011
While visual improvement is frequently achieved following the almost universally accepted monthly injection for 3 months initiation phase of Lucentis (ranibizumab), the only proven treatment regime to maintain the initial gain in visual acuity (VA) is the monthly injection of Lucentis. The advantages of this regimen include simplicity and the...

Full Article


Age-related macular degeneration
Mar 28, 2011
In patients with neovascular age-related macular degeneration (AMD) retinal function, as measured using multifocal electroretinography (mfERG), improved following treatment with intravitreal Lucentis (ranibizumab). The electroretinogram (ERG) is a recording of the electrical activity of the retinal cells located at the back of the eye when...

Full Article


Mar 19, 2011
A very interesting time-lapse video using a series fundus photographs during treatment of wet AMD with Lucentis showing exacerbations and remissions over a 2 year...

Full Article


cardiovascular system
Mar 9, 2011
Researchers found that the incidence of arterial thromboembolic events (ATEs, "blood clots") in patients treated with Avastin (bevacizumab) was significantly higher than patients treated with Lucentis (ranibizumab) for exudative age-related macular degeneration (AMD). Lucentis has revolutionized the treatment of age-related macular...

Full Article


CCTV low vision aid
Feb 27, 2011
A new study finds that Lucentis (ranibizumab) significantly improves the vision of patients with very poor baseline visual acuity secondary to neovascular age-related macular degeneration (AMD). Treatment with anti-VEGF drugs has become the standard treatment of choroidal neovascularisation (CNV) because of AMD. However, information is limited...

Full Article


Uveitis
Feb 27, 2011
Intravitreal injections with anti-VEGF agents such as Avastin (bevacizumab) and Lucentis (ranibizumab) have been increasingly used for the treatment of retinal disorders over the past years. Although both drugs are often repeatedly injected in patients with choroidal neovascularizations, serious adverse events are rare. Here, is presented a case...

Full Article


Snow shoveling
Feb 27, 2011
The onset of wet age-related macular degeneration (AMD) occurs more often during the winter months than during the summer months, according to a new study. Some diseases are influenced by seasonal variations, and may worsen or become more prevalent during certain months of the year. For example, previous studies have shown a seasonal variation...

Full Article


Avastin
Feb 27, 2011
Avastin (bevacizumab) is effective in the treatment of parapapillary choroidal neovascularization (CNV), according to a new study. Parapapillary CNV represent an uncommon type of neovascularization that can be associated with several ocular diseases, of which age-related macular degeneration (AMD) is the most common one. Visual acuity was...

Full Article


Age-related macular degeneration
Feb 27, 2011
Combined treatment of reduced-fluence verteporfin photodynamic therapy (PDT), intravitreal Lucentis (ranibizumab), intravitreal dexamethasone and oral minocycline for choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD) was not more effective than combination therapy with standard-fluence PDT plus Lucentis,...

Full Article


Lucentis
Feb 27, 2011
There is less improvement of vision with as-needed intravitreal Lucentis (ranibizumab) than with monthly injections, according to a new study. Ocular anti-VEGF therapy has presented a major breakthrough in the care of patients with exudative AMD, giving rise to a wide array of therapeutic strategies among retinal specialists, with no consensus...

Full Article


SELECT PAGE
First <<  1 2 3 4 5 6 7 8 9 10   >> Last
Most Popular
Less - past - More